Home Australia: Coronavirus vaccine to provide significant boost to GDP in H2 2021
FXStreet News

Australia: Coronavirus vaccine to provide significant boost to GDP in H2 2021

The Goldman Sachs analysts offer their take on the odds of a coronavirus vaccine to be approved by the Australian government and its impact on the economy.

Key quotes

“Expects a vaccine to be approved by the Australian government in Q1 of 2021, distribution in Q2.

Australia achieving herd immunity by the middle of 2021.

From a macro perspective, while near-term growth is likely to remain muted, we think a successful vaccine will provide a significant boost to GDP starting in the second half of 2021, primarily reflecting a more rapid recovery in domestic tourism spending.

More front-loaded rebound in house prices and increasingly likely acceleration in tax cuts should also provide support.

Forecasts for GDP:

In 2020 to fall 4.2%, to rise 4.6% in 2021 and 5.3% growth seen in 2022.” 

FX Street

FX Street

FXStreet is the leading independent portal dedicated to the Foreign Exchange (Forex) market. It was launched in 2000 and the portal has always been proud of their unyielding commitment to provide objective and unbiased information, to enable their users to take better and more confident decisions.